Furthermore, PD-L1 expression in patients with CRC was associated with clinicopathologic and molecular features and a worse outcome in CRC patients with dMMR/MSI-H than those with pMMR/MSI-L (83). The gene discussed is CD274; the disease is colorectal carcinoma.